Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

BK7508 Pharmaceutical Companies

Market Closed 10-23 16:00:00 AEDT

715.76

+0.51

+0.07%

High718.43	Low708.53	Vol42.01M
Open716.12	D1 Closing715.24	Amplitude1.38%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O169.31M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":715.75684,"timestamp":1792731599840,"preClose":715.2449,"halted":0,"volume":42010190,"delay":0,"changeRate":0.000716,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.511963,"latestTime":"10-23 16:00:00 AEDT","open":716.11926,"high":718.4259,"low":708.53217,"amount":169311797,"amplitude":0.013833,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1792969200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1792710000000,1792731600000]],"turnoverRate":0.00167,"increases":6,"decrements":19,"flats":17,"marketCap":103384654957.75,"floatMarketCap":100419180150.1875},"requestUrl":"/m/hq/s/BK7508/tweets","defaultTab":"tweets","newsList":[{"id":"2677905569","title":"Companies Like Orthocell (ASX:OCC) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2677905569","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677905569?lang=en_us&edition=fundamental","pubTime":"2026-10-24 07:06","pubTimestamp":1792796806,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-occ/orthocell-shares/news/companies-like-orthocell-asxocc-are-in-a-position-to-invest-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-occ/orthocell-shares/news/companies-like-orthocell-asxocc-are-in-a-position-to-invest-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","BK4020","OCC.AU","OCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677920295","title":"3 Stocks Riding Demand for Space and Defense Satellite Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2677920295","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677920295?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:40","pubTimestamp":1792759249,"startTime":"0","endTime":"0","summary":"Power in the space economy is quietly concentrating around Elon Musk’s orbit as governments lean on SpaceX launch capacity and Starlink connectivity for defense, diplomacy and disaster response. That pull creates both political risk and potential contract upside, which can ripple far beyond Musk’s private firms. This article spotlights three satellite and defense communications stocks exposed to that same news cycle and explains where investors might see opportunity or prefer some...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3021000-choice1-card/1788942963390","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3021000-choice1-card/1788942963390"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/3-stocks-riding-demand-for-space-and-defense-satellite-commu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/3-stocks-riding-demand-for-space-and-defense-satellite-commu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","LU0205193047.USD","BK7067","LU0757428866.USD","IE00B7SZL793.SGD","UFO","IE00B66KJ199.SGD","LU0205194284.USD","HXL","BK4544","ROKT","BK4564","LU0240878834.USD","BZZ","LU1815336091.USD","IE0031619046.USD","HXL.AU","LU0240877869.USD","ARKX","LU0053671581.USD","BK4187","IE00B19Z4B17.USD","MRCY","LYNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677892126","title":"Immutep Announces Presentation of Quality of Life Data from Eftisarc-Neo Phase Ii Trial at Esmo 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677892126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677892126?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:00","pubTimestamp":1792756801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA7LZWMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677945096","title":"Immutep's Efti Combination Maintains Quality of Life in Phase II Sarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2677945096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677945096?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:16","pubTimestamp":1792739817,"startTime":"0","endTime":"0","summary":"Immutep's Efti Combination Maintains Quality of Life in Phase II Sarcoma TrialImmutep announced Phase II EFTISARC-NEO results showing stable quality of life during preoperative treatment for resectabl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDLc5BNkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677998943","title":"Immutep Publishes Eftisarc-NEO Presentation Showing no Significant Quality-of-Life Deterioration During Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2677998943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677998943?lang=en_us&edition=fundamental","pubTime":"2026-10-23 14:33","pubTimestamp":1792737218,"startTime":"0","endTime":"0","summary":"Immutep Publishes EFTISARC-NEO Presentation Showing No Significant Quality-of-Life Deterioration During TreatmentImmutep published a medical research presentation on quality-of-life results from its p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL53tH5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677948267","title":"Proteomics International Laboratories Set to Start National Rollout of Two Blood Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2677948267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677948267?lang=en_us&edition=fundamental","pubTime":"2026-10-23 14:12","pubTimestamp":1792735969,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories' (ASX:PIQ) national rollout of Promarker D and Promarker Eso blood tests is due to start on Oct. 26 in collaboration with Australian pathology distribution partne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","NHLD","BK7508","BK7048","BK7124","BK7509","HLS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677169099","title":"Dimerix Says Independent Data Supports Investigational Therapy for Kidney Disease; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677169099","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677169099?lang=en_us&edition=fundamental","pubTime":"2026-10-23 09:58","pubTimestamp":1792720682,"startTime":"0","endTime":"0","summary":"Dimerix  said new human data has provided further independent evidence in support of the company's DMX-200 investigational therapy for focal segmental glomerulosclerosis, a disease characterized by scarring in parts of the kidney, according to a Friday filing with the Australian bourse.An independent study of 261 patients found that CCR2, a cell surface receptor that plays a key role in the damage and scarring of the kidney, is a biologically relevant therapeutic target in the disease, reinforcing the mechanism-of-action rationale for DMX-200, per the filing.CCR2 activity, which is an indicator of inflammation, was found to be significantly elevated in kidney samples from patients with focal segmental glomerulosclerosis compared with healthy controls, the company said.DMX-200 inhibits the CCR2 receptor and is being evaluated by Dimerix in a fully recruited phase 3 study.The company's shares fell 5% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","DXB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677541916","title":"Hexcel (HXL) Stock Price Sinks As Q3 Results Meet A Margin Reset","url":"https://stock-news.laohu8.com/highlight/detail?id=2677541916","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677541916?lang=en_us&edition=fundamental","pubTime":"2026-10-23 08:49","pubTimestamp":1792716560,"startTime":"0","endTime":"0","summary":"Hexcel just reported Q3 2026 and the stock paid the price. Shares dropped about 9.5% today to US$81.27, even though the headline was solid aerospace execution with revenue of US$496.4m and basic EPS of roughly US$0.51.\nThe market focused on the step down from Q2 profitability and punished the stock hard in a single session. The financials instead tell a story of an aerospace supplier still growing its top line while absorbing the short term cost hit of restarting production lines and hiring...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3021000-choice1-card/1788942963390","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3021000-choice1-card/1788942963390"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/hexcel-hxl-stock-price-sinks-as-q3-results-meet-a-margin-res","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/hexcel-hxl-stock-price-sinks-as-q3-results-meet-a-margin-res","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0240878834.USD","BK7508","LU0205193047.USD","BK7067","HXL.AU","ITA","BK4588","LU0205194284.USD","HXL","LU0053671581.USD","BK4187","LU0240877869.USD","ROKT","BZZ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196498476","title":"ETF Daily | COHQ Surges 26%; AXTQ, AAOZ Jump 25%; SOXS Rallies 21%; ZSL Gains 12%; Optical Hardware Weakness Lifts Bears","url":"https://stock-news.laohu8.com/highlight/detail?id=1196498476","media":"ETF Tracker","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196498476?lang=en_us&edition=fundamental","pubTime":"2026-10-23 08:30","pubTimestamp":1792715400,"startTime":"0","endTime":"0","summary":"Market OverviewUS stocks tumbled on Thursday and the Nasdaq posted its steepest daily drop since early June as a batch of high-profile earnings reports ignited fresh fears about the AI spending...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e426da9b0703426f963fa150b0854bd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVV","LU2322448791.USD","03086","SPYQ","PICK","SSO","BK4588","SSG","QLD","SG9999014039.USD","BK4148","LVIG","SMH","XLPD","LU0289739343.SGD","BK4020","FLGV","AXTQ","LU1861215975.USD","LU2095319765.USD","AAOI","LU2294711713.HKD","IE00BKPKM429.USD","BK7508","IE00BN0W2T93.GBP","LU0205193047.USD","SOXS","TBJL","LU2543165471.USD","BK4570","GPIQ","SOXQ","DUST","BK7113","FOTO","SIMX","AIS","SPOG","SPUU","BK4532","BWX","AAOG","SGOL","IE0031619046.USD","MTSI","YGLD","TEKX","BGLD","HK0000304797.USD","DGP","LU1992135472.HKD","GOAU","BK4534","BCDF","BK4571","LU2357305700.SGD","YXI","LU2265009873.SGD","AXTU","LU0240878834.USD","DBC","SGXZ81514606.USD","LU0511384066.AUD","SPDN","DRN","IE00B66KJ199.SGD","SQQQ","NAPR","SPY","BWZ","EGGY","GLL","TQQY","SDS","NUGT","BK4108","LU0240877869.USD","SPLB","YSPY","IE00B3QW5Z07.USD","LU2360106780.USD","UCO","TQQQ","07522","GDXW","LU2272731865.HKD","LU2362541273.HKD","SIVR","BERZ","HK0000304805.HKD","FPS","LU0289961442.SGD","QMAR","SPYM","CHPS","LU2931357623.SGD","SHY","USG","IE00BQXX3D17.EUR","LU2272731782.SGD","BK4581","IE00B7SZL793.SGD","LU0056508442.USD","SPXU","FTXL","VCLT","IAUI","LU1861220033.SGD","UPRO","AAOX","07568","COHH","BK4568","LU0823414551.USD","SOXL","SPOT","LU0274383776.USD","LU0823414478.USD","LU1992135399.USD","CWEB","LU2362541513.USD","LU2360107168.USD","SPYU","DULL","DGZ","GLDM","BBIB","DZZ","BK4533","FWD","BK4551","LAZR","LU2250418816.HKD","USD","CHPY","PSI","SPXL","LU1983260115.SGD","MRNA","AGQ","IE00BN0W2W23.USD","LU0786609619.USD","SGOV","LUMA","KWEB","QQQ","SMHX","TLTI","LU0012050646.USD","FXP","AXTX","AXTC","KGLD","MTSG","SPXS","SPYH","XPP","LU2210149790.SGD","COHX","LU2089985449.USD","SG9999002950.SGD","LCLG","GLD","IE00BN0W2V16.EUR","ITB","NJAN","03034","DRV","LITC","LU2322448957.HKD","IE0004445239.USD","IE00BGHQF748.EUR","GBUG","SPRX","ASHR","BK4585","SPTL","QQQP","CEF","QQQM","TFJL","82822","FPSX","BK4157","PSQ","FGDL","LU0348723411.USD","BK4112","TSYW","XHB","LU2211815571.USD","MMAX","OUNZ","IE00B19Z4B17.USD","IGLD","LU1303367103.USD","LU2098885051.SGD","TLTW","LITZ","IDNA","07266","GLTR","LITX","LU0314104364.USD","SG9999014021.USD","AAOZ","IAU","LU2290526834.HKD","QID","BK4141","XLP","AXTI","LU0205194284.USD","SHNY","QQQX","SOXY","GLDY","BK4593","IE00BQXX3F31.USD","ASHS","BK4550","LU2506951792.HKD","BK4526","SG9999014013.SGD","LITG","IE00B64PRP62.GBP","BK4614","LU2210150020.SGD","LU2272731600.USD","QDEC","SMAX","BK4139","SOXX","LITE","SH","IEF","BK7067","SIMO","TTMI","MRNY","YINN","IEI","CHAU","UGL","SCO","LU2249611893.SGD","LU1852331112.SGD","SGXZ51526630.SGD","WDNA","AXTL","NJUL","VOO","XME","YANG","DMAX","AAAU","TLTX","TTMX","BAR","BBLB","COHR","02843","FDN","GNOM","IAUM","MRNX","TLT","LU2473716301.USD","IE00BQXX3C00.GBP","FLCH","BBSB","LU1548497426.USD","USO","ZSL","COHC","BK4548","LU2357125470.USD","XSD","SHV","BEGS","LU1720051017.SGD","LU0266013472.USD","ISHG","XITK","LU1804176565.USD","HIBL","LGHT","COHQ","BK4501","LU0106261612.USD","NOCT","GDXY","SLV","LU2362540622.SGD","09834","LU1720051108.HKD","IGOV","LITU","TLH","SGXZ99366536.SGD","XLPU","82823","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677997487","title":"Prescient Therapeutics Ltd-Change of Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2677997487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677997487?lang=en_us&edition=fundamental","pubTime":"2026-10-23 06:45","pubTimestamp":1792709140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nTUE6F2X39:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","PTX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677992961","title":"Paradigm Biopharmaceuticals Ltd-Extension of Convening Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2677992961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677992961?lang=en_us&edition=fundamental","pubTime":"2026-10-23 05:49","pubTimestamp":1792705743,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nTUE1BX6KG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PAR.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677994496","title":"Morningstar Says New CSL CEO Removes Uncertainty, but Stock Remains Overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2677994496","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677994496?lang=en_us&edition=fundamental","pubTime":"2026-10-23 05:12","pubTimestamp":1792703544,"startTime":"0","endTime":"0","summary":"BUZZ-Morningstar says new CSL CEO removes uncertainty, but stock remains overvalued** Morningstar maintains its A$165 fair value estimate on Australia's biotech supplier CSLCSL.AXfollowing theappointment of Deborah Waterhouseas chief executive and managing director from February 2027** Says appointment removes leadership uncertainty and views Waterhouse as a credible choice to execute CSL's turnaround plan** Investment & research firm says Waterhouse's experience renewing ViiV's HIV portfolio and commercialising new medicines is relevant as CSL faces increased competition in its core plasma business** Morningstar expects key priorities for the new CEO to include improving returns on invested capital, which fell to about 10% from 25% over the past decade, lowering plasma collection costs and determining the future of Seqirus** However, it argues that CSL shares are overvalued** Stock is up over 13% YTD, as of last close","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nL4N46829V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7508","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677944939","title":"Australian Shares Slip as Fortescue, Santos Drag; Banks Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2677944939","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677944939?lang=en_us&edition=fundamental","pubTime":"2026-10-22 14:23","pubTimestamp":1792650200,"startTime":"0","endTime":"0","summary":"Australian shares slip as Fortescue, Santos drag; banks riseOct 22 (Reuters)-Australian shares slipped on Thursday as Fortescue's operational challenges and Santos' weak guidance weighed on heavyweigh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nL4N4680CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHP.AU","LU0831103253.SGD","BK7511","LU0264606111.USD","BK7508","LU0612318971.USD","LU1078025761.USD","LU0075056555.USD","LU0898667661.SGD","SG9999001143.SGD","CSL.AU","LU0572939691.SGD","LU0171293334.USD","LU0955669360.SGD","LU0572940350.SGD","FMG.AU","LU0971552830.HKD","BK7501","LU1130305938.SGD","LU0266512127.USD","WDS.AU","LU0456854461.SGD","LU0345777147.USD","LU2463526074.USD","LU1302929846.USD","LU0788109121.HKD","BK7067","IE00BWDBJ516.SGD","RIO.UK","STO.AU","IE00BQJZX424.USD","LU1023059493.AUD","LU0011963245.USD","BK7507","LU0345781412.USD","LU0955648018.USD","LU1309081286.SGD","LU0955623706.USD","LU0630314457.HKD","LU1487256676.USD","BK7095","IE0034235071.USD","IE00B3M56506.USD","LU0654597011.USD","LU1481599808.USD","LU1481600234.SGD","LU0505663152.USD","LU1064927863.SGD","BK5111","SG9999002521.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677893517","title":"Australian Shares Fall; Shareholders, Others Urge APA Group to Disclose Viability of Proposed Northern Territory Gas Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2677893517","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677893517?lang=en_us&edition=fundamental","pubTime":"2026-10-22 13:40","pubTimestamp":1792647607,"startTime":"0","endTime":"0","summary":" Australian shares closed lower on Thursday amid a broad-based sell-off in Asian shares.The S&P/ASX 200 Index fell 0.43% or 38.10 points to close at 8,793.20.The index was weighed down by the...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XJO.AU","BK7511","BBOZ.AU","BK7015","GEAR.AU","CSL.AU","ABB.AU","BK7148","SLF.AU","EIGA.AU","IMLC.AU","OZF.AU","XKO.AU","E200.AU","BK7042","XAO.AU","QFN.AU","BEAR.AU","APA.AU","STW.AU","VAP.AU","OZR.AU","IIGF.AU","IOZ.AU","BK7067","BK7501","TPG.AU","IISV.AU","ZYAU.AU","QRE.AU","DACE.AU","BK7508","VAS.AU","GIVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677095850","title":"Mesoblast (ASX:MSB) Shares Climbed, What Is Driving Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2677095850","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677095850?lang=en_us&edition=fundamental","pubTime":"2026-10-22 12:59","pubTimestamp":1792645196,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) is back in focus after the FDA approved its cell therapy Ryoncil. Broad commercial and Medicaid coverage is sharpening attention on how this could influence the group’s future revenue mix.\nRecent trading tells a mixed story. The A$1.86 Mesoblast share price has climbed 5.68% on a 1 day basis, yet the 30 day share price return is down 12.68% and the year to date share price return has fallen 32.85%. At the same time, the 3 year total shareholder return of over 4x signals...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-shares-climbed-what-is-driving-fresh-attent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-shares-climbed-what-is-driving-fresh-attent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","MSB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677938909","title":"Vita Life Sciences And 2 Australian Biotech Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2677938909","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677938909?lang=en_us&edition=fundamental","pubTime":"2026-10-22 11:34","pubTimestamp":1792640089,"startTime":"0","endTime":"0","summary":"Australian biotech stocks sit in a curious spot right now. A global push to fix critical web security flaws is reminding investors how quickly a single breakthrough can reshape entire industries, and the same pattern often plays out in medical science. That mix of risk and potential windfalls is drawing fresh attention to local lab-driven businesses. This article walks through three promising biotech stocks from the screener that may be worth a closer look.\nThe three Australian biotech stocks...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/vita-life-sciences-and-2-australian-biotech-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/vita-life-sciences-and-2-australian-biotech-stocks-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZYAU.AU","GIVE.AU","BK7508","EIGA.AU","IOZ.AU","BK4588","MYX.AU","SLF.AU","BK7096","BEAR.AU","IIGF.AU","BK4581","VAP.AU","QRE.AU","VLS.AU","DACE.AU","QFN.AU","XAO.AU","GEAR.AU","STW.AU","BBOZ.AU","OZR.AU","IISV.AU","IMLC.AU","E200.AU","VAS.AU","XKO.AU","CUV.AU","BK7067","XBI","XJO.AU","BK4585","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677544982","title":"CSL's CEO Pick Has Pros and Cons for Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2677544982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677544982?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:34","pubTimestamp":1792636440,"startTime":"0","endTime":"0","summary":"0234 GMT - CSL's appointment of Deborah Waterhouse as chief executive raises several concerns at Macquarie. One of the investment bank's analysts writes in a note that they like the prospect of Waterhouse continuing the Australian pharmaceutical company's commercial momentum. However, they point out that she has no plasma or rare-disease experience, and that CSL's core businesses have a wide therapeutic and commercial scope. They also observe that Waterhouse has also never been in a public-markets facing role and will be located in the U.K., far from CSL's core manufacturing and major markets. Macquarie has a neutral rating on the stock and a target price of 174.00 Australian dollars. Shares are down 0.2% at A$195.64.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7508","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677816149","title":"ASX Says Genetic Technologies to be Removed from Official List","url":"https://stock-news.laohu8.com/highlight/detail?id=2677816149","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677816149?lang=en_us&edition=fundamental","pubTime":"2026-10-22 09:23","pubTimestamp":1792632236,"startTime":"0","endTime":"0","summary":"BRIEF-ASX Says Genetic Technologies To Be Removed From Official ListOct 22 (Reuters)-Genetic Technologies LtdGTG.AX:GENETIC TECHNOLOGIES WILL BE REMOVED FROM OFFICIAL LIST ON 22 OCTFurther company coverage:GTG.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN467242:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","GTG.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677298583","title":"CSL Faces Shareholder Class Action Over Alleged Disclosure Breaches, Fiscal 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2677298583","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677298583?lang=en_us&edition=fundamental","pubTime":"2026-10-22 07:25","pubTimestamp":1792625142,"startTime":"0","endTime":"0","summary":"CSL  has disclosed that a shareholder class action was filed in the Supreme Court of Victoria on Wednesday, alleging breaches of Australian corporate, consumer and securities laws over statements about its medium-term performance and fiscal 2026 revenue and net profit expectations, according to a Thursday filing with the Australian bourse.The proceedings cover investors who acquired interests in certain CSL securities between Feb. 11, 2025, and May 11, and allege failures to meet continuous disclosure obligations and misleading representations, the filing said.The company denied any liability, asserting that it had consistently fulfilled its disclosure obligations and would vigorously defend the proceedings, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7067","BK7511","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677198311","title":"Australia's CSL Hit with Shareholder Class Action Suit over Earnings Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2677198311","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677198311?lang=en_us&edition=fundamental","pubTime":"2026-10-22 07:00","pubTimestamp":1792623625,"startTime":"0","endTime":"0","summary":"UPDATE 3-Australia's CSL hit with shareholder class action suit over earnings guidanceOct 22 (Reuters)-Australia's CSLCSL.AXwas hit with a shareholder class action suit on Thursday that accuses the va","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nL4N46721T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","BK7067","LU0545562505.USD","LU1046248800.SGD","LU1228905540.USD","BK7508","LU0225284248.USD","LU0971552830.HKD","LU0203347892.USD","LU1983299246.USD","LU1202635105.USD","IE00BWDBJ516.SGD","BK7501","LU0225771236.USD","LU1481600234.SGD","LU0306806265.USD","LU2646069778.SGD","LU0161305163.EUR","GSK.UK","BK5011","IE0034235071.USD","LU0306807586.USD","LU1400636491.USD","SGXZ57979304.SGD","LU0225283273.USD","LU0321505868.SGD","LU1670756490.USD","SG9999013999.USD","LU2089984988.USD","LU2468319806.SGD","LU1015430645.USD","LU0575583348.USD","LU0971552673.USD","LU0987226296.USD","LU1064927863.SGD","LU0321505439.SGD","LU1481599808.USD","LU1228905037.USD","LU1645745479.HKD","LU0109981661.USD","LU1302929846.USD","SG9999001176.USD","IE00B3T34201.USD","BK7511","LU0557290698.USD","LU0058720904.USD","CSL.AU","LU1400636657.SGD","LU0289739699.SGD","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0135},{"period":"1month","weight":0.0132},{"period":"3month","weight":0.0199},{"period":"6month","weight":0.0599},{"period":"1year","weight":0.0778},{"period":"ytd","weight":0.0507}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}